Current Income Tax Expense (Benefit) of PDS Biotechnology Corp from 31 Mar 2019 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary: PDS Biotechnology Corp quarterly Current Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2019 to 31 Mar 2025.
PDS Biotechnology Corp Current Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $0.
Source SEC data: View on sec.gov

Current Income Tax Expense (Benefit), Quarterly (USD)

PDS Biotechnology Corp Quarterly Current Income Tax Expense (Benefit) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025		$0	$0		01 Jan 2025	31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q1 2024		$0	$0		01 Jan 2024	31 Mar 2024	10-Q	15 May 2024	2024	Q1
Q1 2023		$0	$0		01 Jan 2023	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q1 2022		$0	$0		01 Jan 2022	31 Mar 2022	10-Q	11 May 2022	2022	Q1
Q1 2021		$0	$0		01 Jan 2021	31 Mar 2021	10-Q	13 May 2021	2021	Q1
Q1 2020		$0	$0		01 Jan 2020	31 Mar 2020	10-Q	13 May 2020	2020	Q1
Q1 2019		$0			01 Jan 2019	31 Mar 2019	10-Q	14 May 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.